T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW
3,030.00
+150.00 (5.21%)
Aug 8, 2025, 3:30 PM KST
Elevation Oncology Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
TTM | FY 2024 | FY 2023 |
---|
Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
---|
| 11,715 | 16,672 | 20,228 |
| 1,466 | - | 22,000 |
| - | 603.74 | 9,519 |
Cash & Short-Term Investments | 13,181 | 17,276 | 51,747 |
| - | -66.62% | - |
| 77.66 | 2,251 | 1,476 |
| - | 814.85 | 612.79 |
| 77.66 | 3,066 | 2,088 |
| 4,527 | 4,717 | 2,478 |
| - | 561.16 | 374 |
| 3,671 | 674.41 | 871.45 |
| 21,457 | 26,294 | 57,558 |
Property, Plant & Equipment | 61,457 | 61,330 | 34,836 |
| 2,417 | 2,285 | 2,996 |
| 960.81 | 978.48 | 831.24 |
Long-Term Deferred Charges | 313.02 | 350.86 | - |
| 7,268 | 7,215 | 3,595 |
|
| 133.08 | 503 | 13.31 |
| - | 584.66 | 362.23 |
| 23,596 | 22,468 | 28,299 |
Current Portion of Leases | - | 752.09 | 1,019 |
| - | - | 149.35 |
Other Current Liabilities | 14,553 | 14,196 | 21,106 |
Total Current Liabilities | 38,282 | 38,503 | 50,949 |
| 22,896 | 22,490 | 16,200 |
| - | 345.7 | 503.38 |
Other Long-Term Liabilities | 10,677 | 10,035 | 966.07 |
|
| 10,773 | 10,773 | 10,762 |
Additional Paid-In Capital | 145,367 | 145,367 | 145,327 |
| -143,724 | -138,331 | -130,518 |
Comprehensive Income & Other | 6,544 | 6,401 | 5,627 |
| 18,961 | 24,211 | 31,197 |
|
Total Liabilities & Equity | 93,872 | 98,453 | 99,816 |
| 46,492 | 46,056 | 46,021 |
| -33,311 | -28,780 | 5,725 |
| -1540.23 | -1336.10 | 270.01 |
Filing Date Shares Outstanding | 21.55 | 21.55 | 21.52 |
Total Common Shares Outstanding | 21.55 | 21.55 | 21.52 |
| -16,825 | -12,209 | 6,609 |
| 879.99 | 1123.65 | 1449.43 |
| 18,000 | 23,233 | 30,366 |
Tangible Book Value Per Share | 835.40 | 1078.24 | 1410.81 |
| 24,290 | 24,290 | 9,745 |
| 25,380 | 21,568 | 4,072 |
| 8,671 | 20,378 | 4,535 |
| 960.43 | 5,706 | 17,476 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.